
Black Rose Industries Posts Robust Q1 FY27 Performance; Declares Interim Dividend
Black Rose Industries Ltd. reported a strong performance in the first quarter of fiscal year 2027 (Q1 FY27), with revenue and profit after tax increasing by 48% and 146%, respectively, compared to the same period last year. The growth was attributed to improved margins and robust activity within the distribution business across key product categories. Citing the company's strong operational and financial status, the Board of Directors declared an interim dividend of ₹2 per equity share for FY27.The standalone results for Q1 FY27 showcased significant increases in profitability while revenue moderated sequentially following high customer off-take observed in Q4 FY26.
Financial Performance Highlights
Standalone revenues and profits for Q1 FY27, when compared to Q1 FY26 and Q4 FY26, are detailed below (all figures in Rs. crores):| Metric | Q1 FY27 | Q1 FY26 | Change vs Q1 FY26 | Q4 FY26 | Change vs Q1 FY27 |
|---|---|---|---|---|---|
| Revenue | 90.14 | 60.89 | +48% | 104.78 | -14% |
| EBITDA | 15.44 | 6.89 | +124% | 13.76 | +12% |
| PBT | 14.14 | 5.79 | +144% | 12.29 | +15% |
| PAT | 10.41 | 4.24 | +146% | 9.42 | +11% |
Segment and Key Indicator Review
The company's segment-wise results for Q1 FY27 and Q1 FY26 further reflect the performance across different business units:| Year | Distribution Sales (Rs. crores) | Distribution EBITDA (Rs. crores) | Manufacturing Sales (Rs. crores) | Manufacturing EBITDA (Rs. crores) | Unallocated Revenue (Rs. crores) | Unallocated EBITDA (Rs. crores) | Total Revenue (Rs. crores) | Total EBITDA (Rs. crores) |
|---|---|---|---|---|---|---|---|---|
| Q1 FY27 | 62.72 | 10.47 | 26.35 | 7.27 | 1.07 | -2.30 | 90.14 | 15.44 |
| Q1 FY26 | 32.80 | 1.75 | 26.81 | 6.06 | 1.28 | -0.92 | 60.89 | 6.89 |
Key financial indicators (standalone) during the quarter include:
| Parameter | Q1 FY27 | Q1 FY26 | Q4 FY26 |
|---|---|---|---|
| Distribution: Manufacturing Revenue | 2.38 : 1 | 1.22 : 1 | 2.52 : 1 |
| Debt: Equity Ratio | 0.001 | 0.006 | 0.001 |
| Quarterly Interest Coverage Ratio (times) | 59.6 | 29.2 | 29.2 |
| Quarterly Inventory Turnover Ratio (times) | 1.16 | 0.68 | 1.35 |
| Quarterly Return on Equity | 23.2% | 11.0% | 22.3% |
| Current Ratio | 4.38 | 4.52 | 4.65 |
| Quick Ratio | 2.92 | 2.07 | 3.19 |
| EBITDA Margin | 17.33% | 11.5% | 13.23% |
| Net Profit Margin | 11.68% | 7.1% | 9.05% |
Business Update: Manufacturing Division
The manufacturing division showed a resilient performance in Q1 FY27, maintaining broadly unchanged overall revenue compared to both Q1 FY26 and Q4 FY26. While sequential volumes were lower due to customer inventory adjustments and softer demand in the first half of the quarter, improved product realization and favorable pricing trends supported profitability, underscoring the division's market strength.In Acrylamide Liquid, volumes remained steady compared to the previous year, supported by consistent demand. Sequentially, however, volumes moderated as demand was impacted by elevated prices and a wait-and-watch approach adopted by customers following sharp corrections in Acrylonitrile prices. Key raw material, Acrylonitrile, declined from approximately $1,800/MT at the beginning of the quarter to around $1,500/MT by quarter-end. Despite lower sequential volumes, profitability was supported by improved sales realizations and a higher spread.
For solid acrylamide, which the company is the sole global manufacturer of outside China, Q1 FY27 volumes were in line with the preceding quarter. Sales realizations were significantly stronger compared to Q4 FY26, driven by elevated market prices despite stable domestic demand.
The N-Methylol Acrylamide (NMA) division saw moderated volumes compared to both quarters, primarily due to reduced procurement by a key domestic customer following high offtake in March. The company continued expanding its market position through new client acquisitions during the period.
Business Update: Distribution Division
The distribution business achieved strong year-on-year improvements in turnover and volumes in Q1 FY27. This growth was driven by higher sales across most key products and improved realizations, capitalizing on market price increases following events concerning the West Asia conflict. Sequentially, however, volumes and turnover moderated compared to Q4 FY26, which had benefited from elevated purchases amid supply concerns at the start of the conflict. Profitability improved during the quarter, supported by a stronger spread across key products, the benefits of the stock-and-sale model, and healthy export volumes dedicated to the US oil & gas sector.Outlook and Strategic Projects
Manufacturing Division Outlook:The division expects continued strength in the upcoming quarter. Acrylamide liquid exports are anticipated to increase despite higher freight costs, supported by market expansion and ongoing customer additions. Demand for N-Methylol Acrylamide (NMA) is expected to remain steady, while acrylamide solid volumes are projected to improve.
Distribution Division Outlook:
The distribution business anticipates improved sales volumes in Q2, driven by strong supplies and healthy demand across various end-use segments. Market prices are expected to maintain stability, ensuring a conducive operating environment. Merchant exports to the US oil & gas sector are also forecast to remain robust, contributing to improved performance in the next quarter.
Projects and Expansions:
The company continued its strategic R&D and capacity expansion efforts during the quarter. The Polyacrylamide (PAM) solid project advanced into the piloting stage and is scheduled for commercialization in subsequent quarters. Development work on downstream products based on acrylamide chemistry is progressing as planned, and a decision regarding the specialty amines project collaboration with Koei Chemical Company, Ltd. is anticipated within the current year.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.